{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:23:03Z","timestamp":1791667383630,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.07.047","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D44-D47","source":"Crossref","is-referenced-by-count":56,"special_numbering":"S4","title":["Clostridium perfringens vaccines"],"prefix":"10.1016","volume":"27","author":[{"given":"Richard W.","family":"Titball","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.07.047_bib1","series-title":"Plague wars: a true story of biological warfare","author":"Mangold","year":"1999"},{"key":"10.1016\/j.vaccine.2009.07.047_bib2","unstructured":"Butler R. UNSCOM's Comprehensive Review. 1999 [cited May 15, 2009]; Available from: http:\/\/cns.miis.edu\/iraq\/ucreport\/."},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.07.047_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00325481.1996.11946109","article-title":"Gas gangrene\u2014potential for hyperbaric oxygen therapy","volume":"99","author":"Stephens","year":"1996","journal-title":"Postgrad Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.07.047_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/jcpa.2001.0514","article-title":"Effects of intravenous injection of Clostridium perfringens type D epsilon toxin in calves","volume":"126","author":"Uzal","year":"2002","journal-title":"J Comp Pathol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.07.047_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/104063870401600506","article-title":"The pathology of peracute experimental Clostridium perfringens type D enterotoxemia in sheep","volume":"16","author":"Uzal","year":"2004","journal-title":"J Vet Diagn Invest"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.07.047_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2958.1995.tb02234.x","article-title":"Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas-gangrene","volume":"15","author":"Awad","year":"1995","journal-title":"Mol Microbiol"},{"issue":"September (38)","key":"10.1016\/j.vaccine.2009.07.047_bib7","doi-asserted-by":"crossref","first-page":"24433","DOI":"10.1074\/jbc.273.38.24433","article-title":"UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C","volume":"273","author":"Flores-Diaz","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.07.047_bib8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0003-9861(76)90290-3","article-title":"Studies on the hemolytic and hydrolytic actions of phospholipases against mammalian erythrocyte membranes","volume":"173","author":"Taguchi","year":"1976","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.vaccine.2009.07.047_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01872421","article-title":"Effect of Clostridium perfringens phospholipase C (alpha-toxin) on the human diploid fibroblast membrane","volume":"16","author":"Mollby","year":"1974","journal-title":"J Membr Biol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.07.047_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/1447","article-title":"Structure of the key toxin in gas gangrene","volume":"5","author":"Naylor","year":"1998","journal-title":"Nat Struct Biol"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2009.07.047_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/jmbi.1999.3279","article-title":"Characterisation of the calcium-binding C-terminal domain of Clostridium perfringens alpha-toxin","volume":"294","author":"Naylor","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2009.07.047_bib12","series-title":"The comprehensive sourcebook of bacterial protein toxins","first-page":"310","article-title":"Membrane-damaging and cytotoxic phospholipases","author":"Titball","year":"1999"},{"key":"10.1016\/j.vaccine.2009.07.047_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/bmj.1.4350.683","article-title":"The treatment of gas gangrene","volume":"II","author":"MacLennan","year":"1944","journal-title":"Br Med J"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.07.047_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tim.2008.09.005","article-title":"Rethinking our understanding of the pathogenesis of necrotic enteritis in chickens","volume":"17","author":"Van Immerseel","year":"2009","journal-title":"Trends Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.047_bib15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0264-410X(93)90051-X","article-title":"A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene","volume":"11","author":"Williamson","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.07.047_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1086\/422691","article-title":"Immunization with C-domain of alpha-toxin prevents lethal infection, localises tissue injury and promotes host response to challenge with viable Clostridium perfringens","volume":"190","author":"Stevens","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.047_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1099\/13500872-142-1-191","article-title":"Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals","volume":"142","author":"Ginter","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2009.07.047_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.micpath.2007.05.004","article-title":"Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C","volume":"43","author":"Neeson","year":"2007","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.047_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/vim.1999.12.97","article-title":"Recombinant vaccinia viruses protect against Clostridium perfringens alpha-toxin","volume":"12","author":"Bennett","year":"1999","journal-title":"Viral Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.047_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/CVI.00457-07","article-title":"Recombinant attenuated Salmonella enterica serovar typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens","volume":"15","author":"Zekarias","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.047_bib21","first-page":"339","article-title":"Salmonella vaccines for use in humans: present and future perspectives","volume":"26","author":"Garmory","year":"2002","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2009.07.047_bib22","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/IAI.00686-08","article-title":"Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis","volume":"76","author":"Hoang","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.047_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.anaerobe.2005.06.003","article-title":"Immunization with an alpha toxin variant 121A\/91-R212H protects mice against Clostridium perfringens alphatoxin","volume":"12","author":"Schoepe","year":"2006","journal-title":"Anaerobe"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2009.07.047_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006206216220","article-title":"Antibody response in goats vaccinated with liposome-adjuvanted Clostridium perfringens type D epsilon toxoid","volume":"23","author":"Uzal","year":"1999","journal-title":"Vet Res Commun"},{"issue":"17","key":"10.1016\/j.vaccine.2009.07.047_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/vr.143.17.472","article-title":"Variability of serum antibody responses of goat kids to a commercial Clostridium perfringens epsilon toxoid vaccine","volume":"143","author":"Uzal","year":"1998","journal-title":"Vet Record"},{"issue":"415","key":"10.1016\/j.vaccine.2009.07.047_bib26","first-page":"9","article-title":"Inflammatory response to clostridial vaccines in feedlot cattle","volume":"204","author":"Stokka","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.07.047_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1099\/00221287-144-2-333","article-title":"Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice","volume":"144","author":"Oyston","year":"1998","journal-title":"Microbiology"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.07.047_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nsmb804","article-title":"Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin","volume":"11","author":"Cole","year":"2004","journal-title":"Nat Struct Mol Biol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2009.07.047_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1574-6968.1987.tb02219.x","article-title":"Histidine residues in Clostridium perfringens epsilon toxin","volume":"41","author":"Sakurai","year":"1987","journal-title":"FEMS Microbiol Lett"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.07.047_bib30","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/IAI.58.8.2487-2492.1990","article-title":"Anti-idiotypic antibody-induced protection against Clostridium perfringens type D","volume":"58","author":"Percival","year":"1990","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T03:20:11Z","timestamp":1590204011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":30,"alternative-id":["S0264410X09010524"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}